Evidence-Based Medicine Guidelines
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456655/all/Oral_versus_intravenous_steroids_for_treatment_of_relapses_in_multiple_sclerosis.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456655/all/Oral_versus_intravenous_steroids_for_treatment_of_relapses_in_multiple_sclerosis. Accessed September 17, 2024.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456655/all/Oral_versus_intravenous_steroids_for_treatment_of_relapses_in_multiple_sclerosis
Oral Versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456655/all/Oral_versus_intravenous_steroids_for_treatment_of_relapses_in_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
ID - 456655
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456655/all/Oral_versus_intravenous_steroids_for_treatment_of_relapses_in_multiple_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
